» Articles » PMID: 36676868

The Interaction of Anthracycline Based Quinone-Chelators with Model Lipid Membranes: H NMR and MD Study

Overview
Date 2023 Jan 21
PMID 36676868
Authors
Affiliations
Soon will be listed here.
Abstract

Anthracycline antibiotics, e.g., doxorubicin, daunomycin, and other anthraquinones, are an important family of antitumor agents widely used in chemotherapy, which is currently the principal method for treating many malignancies. Thus, development of improved antitumor drugs with enhanced efficacy remains a high priority. Interaction of anthraquinone-based anticancer drugs with cell membranes attracts significant attention due to its importance in the eventual overcoming of multidrug resistance (MDR). The use of drugs able to accumulate in the cell membrane is one of the possible ways of overcoming MDR. In the present work, the aspects of interaction of anthraquinone 2-phenyl-4-(butylamino)naphtho[2,3-h]quinoline-7,12-dione) (Q1) with a model membrane were studied by means of NMR and molecular dynamics simulations. A fundamental shortcoming of anthracycline antibiotics is their high cardiotoxicity caused by reactive oxygen species (ROS). The important feature of Q1 is its ability to chelate transition metal ions responsible for ROS generation in vivo. In the present study, we have shown that Q1 and its chelating complexes penetrated into the lipid membrane and were located in the hydrophobic part of the bilayer near the bilayer surface. The chelate complex formation of Q1 with metal ions increased its penetration ability. In addition, it was found that the interaction of Q1 with lipid molecules could influence lipid mobility in the bilayer. The obtained results have an impact on the understanding of molecular mechanisms of Q1 biological activity.

Citing Articles

Molecular assessment of drug-phospholipid interactions consequent to cancer treatment: a study of anthracycline-induced cardiotoxicity.

Ahmed Y, Elkhodary K, Youssef M Sci Rep. 2023; 13(1):22155.

PMID: 38092839 PMC: 10719326. DOI: 10.1038/s41598-023-48184-4.


Metal Complexes of Omadine (-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications.

Selyutina O, Timoshnikov V, Polyakov N, Kontoghiorghes G Molecules. 2023; 28(10).

PMID: 37241949 PMC: 10222870. DOI: 10.3390/molecules28104210.


Odor Discrimination by Lipid Membranes.

Lowry T, Kusi-Appiah A, Fadool D, Lenhert S Membranes (Basel). 2023; 13(2).

PMID: 36837654 PMC: 9962961. DOI: 10.3390/membranes13020151.

References
1.
Myers C, Gianni L, Simone C, Klecker R, Greene R . Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex. Biochemistry. 1982; 21(8):1707-12. DOI: 10.1021/bi00537a001. View

2.
Christidi E, Brunham L . Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021; 12(4):339. PMC: 8017015. DOI: 10.1038/s41419-021-03614-x. View

3.
da Cunha A, Duarte E, Stassen H, Lamy M, Coutinho K . Experimental and theoretical studies of emodin interacting with a lipid bilayer of DMPC. Biophys Rev. 2017; 9(5):729-745. PMC: 5662058. DOI: 10.1007/s12551-017-0323-1. View

4.
Hrelia S, Fiorentini D, Maraldi T, Angeloni C, Bordoni A, Luigi Biagi P . Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim Biophys Acta. 2002; 1567(1-2):150-6. DOI: 10.1016/s0005-2736(02)00612-0. View

5.
Frezard F, Garnier-Suillerot A . Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature. Biochim Biophys Acta. 1998; 1389(1):13-22. DOI: 10.1016/s0005-2760(97)00070-2. View